Electrical Impedance Myography Technology for Quantitative, At-home Muscle Assessment in Amyotrophic Lateral Sclerosis (EIM-At-Home)
This research is being performed to evaluate the reliability and ease of use of the improved mScan™ EIM (electrical impedance myography) device as a potential biomarker for ALS for patients to use in the comfort of their homes. There are three visits required for this study, which will happen at the same time as regularly scheduled visits to the BNI ALS Multidisciplinary Clinic, and will occur approximately every 3-4 months.
In addition to the study visits, participants will complete a number of outcome measures on their own at home, including weekly measurements of voice recordings, EIM assessments, and ALSFRS-R questionnaires. Overall, participants may be in the research study for about 8 months.
Principal Investigator: Jeremy M. Shefner, MD, PhD